An electronic biosensing platform by Ravindran, Ramasamy
 











A Ph.D. Dissertation 
Presented to 
















In Partial Fulfillment 
of the Requirements for the Degree 
of Doctor of Philosophy in the 













































   
Dr. James D. Meindl, Advisor 
School of Electrical and Computer 
Engineering 
Georgia Institute of Technology 
 Dr. John F. McDonald 
School of Biology 
Georgia Institute of Technology 
   
Dr. Muhannad S. Bakir 
School of Electrical and Computer 
Engineering 
Georgia Institute of Technology 
 Dr. Bonnie H. Ferri 
School of Electrical and Computer 
Engineering 
Georgia Institute of Technology 
   
Dr. Gregory W. Book 
Institute for Electronics and 
Nanotechnology 
Georgia Institute of Technology 
  
   


















 My time in graduate school has been full of people I’ve had great experiences with and, in 
countless ways, have given me great opportunities. I learned far more because of the time shared with 
them than I ever could have from a book, lab, or classroom. 
To my Mom and Dad: Thanks shaping me more than anyone else and for teaching me about holding true to one’s 
principles.  
To Dr. James Meindl: Thanks for showing me that intelligence, class, and dignity can co-exist in a life full of stories.  
To Drs. Raghu Murali, Greg Book and Muhannad Bakir: Thanks for all great conversations about life over so 
many lunches and dinners. 
To GSI Mom Jennifer Root and Tina Moseley: Thank you for conveying the spirit of the group so well . 
To Drs. John McDonald and Bonnie Ferri: Thanks for taking the time to be a part of my committee and working 
with all of the graduate students in Biology and ECE. 
To Drs. Mike Hutsel and Greg Triplett: I wouldn’t be here at Tech were it not for you two. Thanks for the bike 
rides, the classes, and times just spent talking in Columbia and Atlanta. 
To Dr. Ron Fox: You taught the best class I’ve ever had in college. 
To Dr. Ken Scarberry: Thanks for showing me the path to logical thinking and consulting . 
To Ian Yang, Kevin Brenner, T. J. Beck, Sarah Bryan, Farhana Zaman, Jenna Fu, Gerald Lopez, and 
Calvin King: It was wonderful working with you over the years and I hope to share many more memories going forward. 
To Scott Hood: You were the perfect sounding board. I don’t need to say more.  
To Jake Sadie: You were right up there in the sounding board department. 
To Gary Spinner, Devin Brown, Joel Pikarsky, Scott Fowler, Eric Woods, Charlie Suh, John Pham, and 
Vinnie Nguyen: Thanks for putting up with a guy that could occasionally be whiney but always had the best of intentions. 
To The Boston Consulting Group: Thanks for giving me the chance to start pursuing my professional life after college. 
 I’ll spend the rest of my life never forgetting the people that I shared those wonderful memories 
with and helped me find myself as a person. It’s a process that I hope never ends because there is such a 
magical world out there with so much to learn about. Thank you again.  
 v 
TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS iv 
LIST OF TABLES viii 
LIST OF FIGURES ix 
LIST OF SYMBOLS AND ABBREVIATIONS xii 
SUMMARY xiv 
CHAPTER 
1 INTRODUCTION 1 
1.1 Pre-history of the Project 1 
1.2 Background 2 
1.3 Sensing Methodologies 5 
1.4 Principles of Operation for a SiNW Sensor 14 
1.5 High-Level Design Considerations 16 
1.6 High-Level Usability Considerations 18 
1.7 The Electronic Microplate 19 
1.8 Overview of the Presented Research 22 
2 SiNW CONSIDERATIONS AND PROCESS DEVELOPMENT 23 
2.1 Background 23 
2.2 Process Development 23 
2.3 Measurement Considerations 28 
2.4 Dry Measurements 31 
 vi 
2.5 Wet Measurements 33 
2.6 Summary 39 
3 CELL-LINE SENSING WITH A LOW-DENSITY ARRAY 40 
3.1 Background 40 
3.2 Cell-Line Low-Density Array Fabrication 40 
3.3 Characterization Measurements 44 
3.4 Arrayed Cell-Line Sensing 47 
3.5 Summary 53 
4 SPION SENSING WITH A LOW-DENSITY ARRAY 54 
4.1 Background 54 
4.2 SPION Low-Density Array Fabrication 54 
4.3 Superparamagnetism 54 
4.4 Functionalized SPION Sensing 55 
4.5 Summary 61 
5 BIOCHEMICAL SENSING WITH A HIGH-DENSITY ARRAY 62 
5.1 Background 62 
5.2 High-Density Array Fabrication 62 
5.3 Characterization Measurements 68 
5.4 pH Ssensing Measurements 74 
5.5 Refinements 77 
5.6 Summary 78 
6 CONCLUSIONS AND FUTURE WORK 79 
6.1 Summary 79 
 vii 
6.2 Future Work 80 
7 APPENDIX 82 
7.1 Device Si, BOX, and HSQ Etch Rates 82 
7.2 Process Development Fabrication Workflow 83 
7.3 Low-Density Array Fabrication Workflow 84 
7.4 High-Density Array Fabrication Workflow 85 
7.5 Plated and Non-Plated High-Density Arrays 87 




LIST OF TABLES 
 
Page 
Table 3.1: Change in surface charge density 51 
Table 3.2: Change in volume charge density 51 
Table 3.3: p-values of HEY versus IOSE 52 
Table 7.1: Device Si, BOX, and HSQ etch rates 82 
Table 7.2: Process development fabrication workflow 83 
Table 7.3: Low-density array fabrication workflow 84 
Table 7.4: High-density array fabrication workflow 85 
 
 ix 
LIST OF FIGURES 
 
Page 
Figure 1.1: A schematic depiction of ELISA 7 
Figure 1.2: Simplified depiction of labeled detection and label-free detection 9 
Figure 1.3: Two amino acids (arginine and glutamic acid) 10 
Figure 1.4: A sequence of mRNA (3’-5’ CGU) 11 
Figure 1.5: Depiction of mass based sensors 12 
Figure 1.6: Depiction of a SiNW sensor 14 
Figure 1.7: The electronic microplate in an example 3 x 3 configuration 20 
Figure 2.1: High-contrast optical image of the SiNW test pattern 24 
Figure 2.2: Three-quarter views of SiNWs of varying widths 25 
Figure 2.3: Complete SiNW with contact pads for metal electrodes 25 
Figure 2.4: Three-quarter view false-color SEM of one end of a SiNW 26 
Figure 2.5: Top-down views of two electrode configurations 27 
Figure 2.6: Images of a fabricated test chip 28 
Figure 2.7: The linear region for a process development device 31 
Figure 2.8: General biasing configuration and terminal polarities 32 
Figure 2.9: Dry IV curves for a process development device 33 
Figure 2.10: Testing setup for preliminary testing 34 
Figure 2.11: Bias induced damage of a SiNW 34 
Figure 2.12: Passivation failure in a test device 35 
Figure 2.13: Dry IV curves before and after oxygen annealing 36 
 x 
Figure 2.14: Testing setup for leakage testing 37 
Figure 2.15: SiNW to PBS leakage currents before and after oxygen annealing 37 
Figure 2.16: Time-dependent response to varying pH solutions 38 
Figure 3.1: Depiction of the low-density array processing workflow 42 
Figure 3.2: CAD layout of a single low density chip 43 
Figure 3.3: Images of a fabricated low-density array chip. 43 
Figure 3.4: Dry IV curves for a low-density array 44 
Figure 3.5: Average and ± two standard deviation ID for 16 sensors in an array 45 
Figure 3.6: Wet ID and gm vs. VGS curves in pH 7.6 PBS for a low-density array 46 
Figure 3.7: Testing setup for arrayed cell line sensing 48 
Figure 3.8: Time-dependent response to HEY and IOSE solutions 49 
Figure 3.9: Percentage difference in ID between HEY and IOSE 50 
Figure 4.1: Amine and carboxyl functionalized SPIONs 55 
Figure 4.2: Testing setup for SPION sensing 56 
Figure 4.3: Time dependent response for a 1 mg/mL SPION solution 57 
Figure 4.4: Time dependent response for a control solution without SPIONs 58 
Figure 4.5: Relationship of the rising time constant with SPION concentration 59 
Figure 4.6: Relationship of the extrapolated ID change with SPION concentration 60 
Figure 5.1: Depiction of the high-density array TSV processing workflow 65 
Figure 5.2: Depiction of the high-density array SiNW and metal processing workflow 66 
Figure 5.3: Depiction of the completed high-density array with wells 67 
Figure 5.4: CAD layout of a single high-density chip 67 
Figure 5.5: Images of a fabricated high-density array chip at various stages 68 
 xi 
Figure 5.6: Testing setup for high-density array sensing 69 
Figure 5.7: Dry IV and ID and gm vs. VGS curves for a non-plated high-density array 71 
Figure 5.8: Dry IV and ID and gm vs. VGS curves for a plated high-density array 72 
Figure 5.9: Nearest-neighbor TSV leakage 74 
Figure 5.10: Time-dependent response to varying pH solutions 75 
Figure 5.11: ID versus pH for a high-density array 76 





LIST OF SYMBOLS AND ABBREVIATIONS 
 
 
3DS  Three-dimensional stacking 
BOE  Buffered oxide etch 
BOX  Buried oxide 
CMOS  Complimentary metal-oxide-semiconductor 
EBL  Electron-beam lithography 
ELISA  Enzyme-linked immunosorbent assay  
FET   Field-effect transistor 
FITC  Fluorescein isothiocyanate 
FWHM   Full width at half maximum 
HSQ   Hydrogen silsesquioxane 
IC  Integrated circuit 
ICP  Inductively coupled plasma 
MEMS    Microelectromechanical systems 
PBS  Phosphate buffered saline 
PECVD  Plasma-enhanced chemical vapor deposition 
RIE  Reactive ion etch 
RTP  Rapid thermal process 
SiNW  Silicon nanowire 
 xiii 
SNP  Single nucleotide polymorphism 
SOI  Silicon-on-insulator 
SPION  Superparamagnetic iron oxide nanoparticles 
TMAH  Tetramethylammonium hydroxide 




The objective of this research was to develop the initial constituents of a highly 
scalable and label-free electronic biosensing platform. Current immunoassays are 
becoming increasingly incapable of taking advantage of the latest advances in disease 
biomarker identification, hindering their utility in the potential early-stage diagnosis and 
treatment of many diseases. This is due primarily to their inability to simultaneously 
detect large numbers of biomarkers. The platform presented here – termed the electronic 
microplate – embodies a number of qualities necessary for clinical and laboratory 
relevance as a next-generation biosensing tool. SiNW sensors were fabricated using a 
purely top-down process based on those used for non-planar CMOS ICs on SOI wafers 
and characterized in both dry and biologically relevant ambients. Canonical pH 
measurements validated the sensing capabilities of the initial SiNW test devices. A low 
density SiNW array with fluidic wells constituting isolated sensing sites was fabricated 
using this process and used to differentiate between both cancerous and healthy cells and 
to capture superparamagnetic particles from solution. TSVs were then incorporated to 
create a high density sensor array, which was also characterized in both dry and PBS 
ambients. The result is the foundation for a platform incorporating versatile label-free 
detection, high sensor densities, and a separation of the sensing and electronics layers. 
The electronic microplate described in this work is envisioned as the heart of a next-
generation biosensing platform compatible with conventional clinical and laboratory 





1.1  Pre-history of the Project 
 Extraordinary advances have been made over the last half-century in 
microelectronics and biology. Integrated circuits (ICs) have grown in complexity from 
tens of crudely interconnected transistors to billions of transistors capable of switching 
on and off in the time a photon travels a few centimeters. Meanwhile, genomics has 
progressed from sequencing a few thousand nucleotide bases in the simplest of viruses 
and microorganisms to starting to elucidate the complex interplay between the three 
billion base pairs in the human genome – regions of which range in purpose from being 
mere evolutionary remnants to the variable coding for antibodies in the adaptive immune 
system. Despite the tremendous progress in these two fields, there has been a negligible 
crossover of technology between the two until recently. As we trend towards 
personalized medicine, there is a tremendous opportunity for collaboration between 
these two historically distinct fields. 
 This project originated as an effort to envision a next-generation biosensing 
platform that takes advantage of recent developments in biology and electronics and use 
those developments to implement components of such a platform from both a physical 
entity and application point of view. 
 2 
1.2 Background 
 Diseases perturb the normal functioning of an organism. In doing so, they trigger 
various measurable changes in the levels and activities of biomolecules. These changes 
can range from an increased production of specific antibodies in response to the 
common cold to a modification of the genome as a result of a retrovirus infection or 
cancer.  
 Traditionally, screening for diseases such as cancer has involved looking at one of 
these biomolecules or more specifically, a biomarker for a given disease. Prominent 
examples of biomarkers include proteins like prostate specific antigen for prostate cancer 
and cancer antigen 125 for ovarian cancer. Unfortunately, these and other biomarkers are 
nowhere near perfect indicators. Accuracy is often around 80 percent or less with a 
significant number of false positive and false negative results. [1-4] This can result in 
expensive and unnecessary further tests and treatment programs in the case of false 
positives or, more detrimentally, a failure to identify a disease in the case of false 
negatives. Both of these situations increase costs, lessen the chances for a positive 
prognosis, and place an undue burden on both the patient and the healthcare system. 
Other aggressive carcinomas like pancreatic cancer are even more challenging to detect 
early. At-risk patients must be regularly followed or screened for indirect markers with 
efficacy in both situations even poorer than with single marker screening. [5, 6] 
 The critical flaw in using single traditional biomarkers for each disease is that 
they often cannot adequately capture the incredibly large number of ways in which 
various diseases affect different individuals. Further, traditional biomarkers are generally 
not conducive to early stage detection – a time when the prognosis is usually dramatically 
 3 
better. [7, 8] The resolution for this, and one that has received a tremendous amount of 
attention since the sequencing of the human genome, is to identify tens or hundreds of 
biomarkers for each disease. [9-11] By screening for an entire palette of biomarkers, a 
much more certain diagnosis can be made. For example, if ten biomarkers exist for a 
disease, a clinician could diagnose with high certainty that a patient has that disease if 
they exhibit seven of those biomarkers. This approach much better accommodates how 
different patients may express different biomarkers for the same disease.  
 Recent advances in genomics have enabled researchers to discover new types of 
biomarkers. For example, cancerous cells often feature several characteristic single 
nucleotide polymorphism (SNP) mutations in their DNA that can be used as effective 
biomarkers. [11] In fact, the entire gene expression sequence including DNA, mRNA, 
transcription factors, the translated proteins, and a number of other associated 
biomolecules is rich in potential biomarkers. [12, 13] Broadly speaking, diseases produce 
a wide range of biomolecules that can serve as effective indicators. These span the 
spectrum from nucleic acids and proteins to metabolites, carbohydrates, and even 
individual ions. Therefore, a useful diagnostic platform should be capable of detecting a 
large variety of biomarkers above and beyond the proteins that have largely served as the 
biomarkers in current immunoassays.  
 The concept of personalized medicine is idealistic, but nonetheless, is something 
that has marched closer and closer to realization over the last decade and will continue to 
do so in the decades going forward. In a world of perfect diagnoses, diseases would 
either manifest themselves in the same manner in all individuals or we would have the 
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capability to identify all possible variations of any given disease across a population. With 
the former clearly not being the case, researchers have turned to the later. [14] 
 There is a tremendous need for a next-generation biosensing platform that is 
capable of effectively screening for large sets of disease biomarkers – thousands or more 
– that more comprehensively describe numerous diseases across numerous individuals. 
Existing general purpose immunoassays used to detect biomarkers such as enzyme-
linked immunosorbent assays (ELISAs) are typically several decades old and do not lend 
themselves to readily scaling to the levels needed to screen for thousands or millions of 
biomarkers – as would be necessary to concurrently screen for multiple cancers and 
other diseases. [15] Some newer technologies are scalable, but are limited in the types of 
biomarkers they can identify. For example, DNA microarrays can screen for thousands 
of SNPs, but are limited to the detection of nucleic acids. [16] Compounding this 
situation, nearly every clinical biosensing technology currently in use employs the use of 
labels such as fluorophores, radioisotopes, or enzymes which are indirect indicators of a 
sensing event. This adds complexity in conducting the assay and limitations in the 
capabilities of that assay. [17] 
 There is simply no highly scalable, general purpose biosensing platform currently 
in widespread use. A next-generation biosensing platform needs to be a substantial step 
forward from decades old existing technologies, take advantage of the latest 
developments in biology and medicine, and have broad applications. It is the objective of 
this research to outline such a biosensing platform and implement and demonstrate 
important aspects of that platform.  
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1.3 Sensing Methodologies 
 Biosensing as applied to assays generally falls into two broad categories – labeled 
and label-free sensing. Methodologies that are complex and reserved for low-throughput 
applications such as mass spectroscopy are not included in this discussion. A 
fundamental drawback of all labeled sensing methodologies is the finite number of 
different biomarkers for which they can simultaneously screen. This limitation manifests 
itself in a number of ways, but looking at optical labels – the most common class of 
labels – effectively illustrates this. All fluorophores, including commonly used ones such 
as cyanine and FITC, are excited around a certain wavelength and emit around a 
different, longer and lower energy, wavelength. The emission wavelength of all 
fluorophores is not a discrete peak, but rather a spectrum with a peak at a given 
wavelength and a FWHM spanning tens of nanometers to either side. This has not been 
a limitation in classical immunoassays that screen for less than a handful of biomarkers 
as there can be sufficient separation of the emission spectra of different fluorophores to 
uniquely identify them. However, at some point, and generally at fewer than ten different 
fluorophores in the visible wavelength region, the emission spectra of a given 
fluorophore begins to overlap with that of its neighbors sufficiently enough that they 
become increasingly difficult to distinguish. [18] 
 One solution would be to use a combination of fluorophores or multiplexing to 
form more unique fingerprints. Protein microarrays often employ this, but even then 
they are only able to push this limit out to a few hundred different biomarkers while 
incurring penalties in the time and cost brought on by the procedures used to combine 
multiple optical labels prior to the assay and then detect them afterwards. [19, 20] 
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Another logical solution would be a label that has a near-discrete emission spectrum. 
Quantum dots offer this capability in principal, but in practice, variance in composition 
and size effectively limit quantum dots, even those that have multiplexed signatures, to a 
few thousand discernible labels. [21, 22] Other labeled approaches ranging from those 
using radioisotopes to surface enhanced Raman spectroscopy suffer from similar 
limitations. [23] Additionally, all labeled sensing methodologies require additional 
processing steps beyond the initial biomarker capture event and these steps only become 
increasingly involved and costly as multiplexing measures are introduced to better 
distinguish between an increased number of biomarkers. 
 Looking at one of the most commonly used conventional labeled methods, 




Figure 1.1: A schematic depiction of ELISA 
 
 ELISA starts off by binding a capture biomolecule, generally a primary antibody, 
to a substrate, usually a microplate. The microplate is then washed to remove any 
unbound primary antibody and blocked with a blocking agent to prevent non-specific 
binding of subsequent biomolecules. The sample, which may or may not contain the 
biomarker or antigen, is then introduced (A). If the antigen is present, the primary 
antibody captures it by one particular epitope or location on the antigen (B). The 
microplate is again washed and a secondary antibody is introduced. If the antigen is 
present, it binds to a different epitope on the antigen. The distinction between the 
primary and secondary antibodies is that the secondary antibody has attached to it an 
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enzyme label. After once more washing the microplate, an indicator chemical is 
introduced that undergoes a catalytic color change in the presence of the enzyme on the 
secondary antibody (C and D), thereby indicating the presence or absence of a biomarker 
antigen. 
 ELISA is a robust, ubiquitous, and low-cost assay, but in its most common form, 
it can only be used to screen for one or a few proteins at a time. Even newer 
implementations of ELISA using multiplexed fluorophore labels are bound by the 
limitations common to all labeled sensing methods and come at the cost of increasing 
the processing steps involved. [24] Unfortunately, from Raman to fluorophores, the 
greater number of distinct biomarkers a particular labeled scheme is able to identify, the 
more disproportionally complex it becomes. [18] 
 A next-generation biosensing platform should be unencumbered by any such 
limitations. It should have no fundamental upper limit to the number of distinct 
biomarkers that can be simultaneously screened and should also ideally require fewer 
processing steps than current methodologies. There has been substantial progress over 
the last decade to that end with the result being the development of numerous label -free 
methodologies. [25-29] A label-free sensor detects a property inherent to the captured 
biomarker, effectively detecting the primary biomarker binding event itself and not a 
secondary binding event as is the case with label based sensors. Because of this 
underlying characteristic, label-free sensors can detect an unlimited number of distinct 
biomarkers in a single assay given their complementary capture biomolecules. The 
following figure depicts the point at which a biomarker capture event can be detected  in 
labeled and label-free sensing. In this case, the capture and secondary biomolecules are 
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depicted as antibodies and the biomarker as an antigen protein but this principle extends 
to schemes involving other biomolecules such as nucleic acids. In the case of the labeled 
method, this is a best case scenario – often subsequent steps are needed as is the case for 
methods like ELISA. 
 
 
Figure 1.2: Simplified depiction of labeled detection and label-free detection 
 
 Biomarkers generally have one or both of two properties – charge and mass. For 
example, nucleic acids have a negative charge due to the phosphate groups on the ribose 
backbone. Other macromolecules such as proteins carry a charge based on where their 
isoelectric point, pI, is relative to the pH of the solution they are in. Similarly, a host of 
other disease biomarkers of interest such as ions and metabolites also carry an electric 
charge. The complex nature of many biomolecules also confers on them a substantial 
mass. Proteins and nucleic acid sequences of note as biomarkers are often tens or 
hundreds of thousands of daltons.  
 To better understand the origin of this charge and mass, let us look at an 
arbitrary amino acid sequence and one of the mRNA sequences that codes for one of 
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those amino acids. First is a sequence of arginine and glutamic acid representative of a 
portion of a protein. At a biological pH of 7.4, such as that of phosphate buffered saline 
(PBS), the arginine NH group highlighted in red is protonated to NH 2
+, lending arginine 
an overall positive charge. Similarly, the glutamic acid OH group highlighted in blue is 
deprotonated to O-, lending glutamic acid an overall negative charge. Since proteins such 
as antibodies are long sequences of amino acids, these charges are summed and become 
a detectable characteristic of the protein sequence, provided the protein is in a solution 
with a pH not equal to its pI, at which point the overall protonation and deprotonation 
of all the amino acids lends the protein a net neutral electric charge. 
 
 
Figure 1.3: Two amino acids (arginine and glutamic acid) 
 
 DNA and mRNA also carry a net charge, but for both, this charge is negative. To 
see this, we can look at a short sequence of mRNA (CGU) which codes for arginine in 
Figure 1.4. The backbones of DNA and mRNA are comprised of ribose sugars linked by 
phosphate groups. These groups, highlighted in blue, carry a negative charge because of 
the single bonded O. This charge is similarly summed over the length of the sequence 
and is a detectable characteristic of the amino acid. 
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 It should also be evident from these two examples that biomolecules also have a 
significant mass. For example, the amino acids in Figure 1.3 have masses of ≈174 and 




Figure 1.4: A sequence of mRNA (3’-5’ CGU) 
 
 Since label-free sensing is centered on directly detecting a captured biomarker 
without an intermediary label, mass and charge, both being in notable abundance in 
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macromolecules comprised of tens to thousands of amino acids and bases or other 
constituents, are the most common candidate properties. Both of these approaches 
minimize processing steps and avoid any limitation in the number of different 
biomarkers that can be simultaneously detected. 
 Mass based sensing is outside the scope of this research, but a cursory discussion 
is useful. There are several variations of mass-based sensors, but typically the mass of the 
captured target biomolecule results in the deflection of a cantilever, the alteration of a 
propagating acoustic wave, or a change in oscillator resonance propert ies, be they 
mechanical or optical. [28, 30-33]  
 
 
Figure 1.5: Depiction of mass based sensors 
On the left, a captured biomarker results in either a deflection of a cantilever or a change 
in the resonance of a resonator. On the right, a captured biomarker alters an acoustic 
wave traveling from left (green) to right (red). 
 
 While their operating principles are sound, mass based sensors do have some 
drawbacks. They are fabricated using MEMS processes, are fabricated on piezoelectric 
substrates, or are fabricated using even more exotic methods in the case of optical 
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resonators. [28, 30, 32, 33]   This adds a level of complexity and cost to their fabrication 
since they cannot be made using traditional cost-effective complimentary metal-oxide-
semiconductor (CMOS) workflows. In many cases, various performance metrics of mass 
based sensors such as the quality factor of resonators degrades in biologically relevant 
environments such as aqueous solutions either by dampening or absorption. [28, 33] The 
actual sensing process is also quite complex and involved, requiring a combination of 
oscillators, transducers, filters, lasers, and high frequency electronics. [28, 30-33] While 
mass based sensing does have potential applications, because of the focus on CMOS 
workflow compatibility and scalability, this research uses charge based sensing. 
 Charge based sensors are generally constructed from semiconductors and are 
operated like conventional transistors. [26, 27, 29, 34] The charge that a captured 
biomarker imparts on the surface of a semiconductor modulates the current flowing 
from source to drain through either an inversion or accumulation channel, much as the 
bias on a gate does in a field-effect transistor (FET). A substantial advantage of a 
properly implemented charge based sensor is its compatibility with top-down CMOS 
fabrication workflows because of this similarity with FETs. 
 In this work, a silicon nanowire (SiNW) is used as the specific implementation of 
charge based sensing. A SiNW based sensor is of particular interest because 
biomolecules can be bound not just to one face of the channel as in planar devices, but 
to the sides as well. [26] This allows for superior modulation of ID. Further, 
commercially fabricated IC FETs are trending away from planar devices and towards 
non-planar multigate or gate-all-around designs that closely resemble SiNWs. [35, 36] 
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This CMOS industry movement means that a SiNW label-free biosensor can be readily 
fabricated using emerging CMOS fabrication workflows.  
 
Figure 1.6: Depiction of a SiNW sensor 
A negatively charged biomarker that is captured on the surface of the sensor induces a 
positive charge within the SiNW. 
 
1.4  Principles of Operation for a SiNW Sensor 
 To better understand the principle of operation of a charge based SiNW 
biosensor, consider a uniformly doped SiNW operated as a majority carrier accumulation 
mode device in the linear region. [37, 38] The total current density reduces to the 
majority carrier drift current density and is given as: 
                 (1.1) 
where q is the elementary charge, µ is the majority carrier mobility, no is the majority 
carrier concentration, and E is the electric field. The total current for a SiNW with a 
rectangular cross-section is: 
                                    (1.2) 
Where h is the height of the SiNW and w is the width of the SiNW.   
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If we assume q, µ, and E to be fixed, then any change in current in the linear region must 
be the result of a change in the carrier concentration, Δn: 
                        (1.3) 
If we assume that any change in n is the result of surface charges, then Δn is equal to: 
 
     
       
     
 
(1.4) 
where σ (q/cm2) is the surface charge density. When a SiNW is used as a biosensor, σ is 
the surface charge density that bound biomolecules impart on the SiNW. Thus, the 
change in current through a SiNW is: 
 
               
       
     
          
(1.5) 
The net current through a SiNW can be described by the following equation:  [37] 
 
                                    
       
     
          
(1.6) 
where no (electrons/cm
3) (is the doping density of the SiNW. Naturally, the capture 
biomolecule itself will have some charge. For the purposes of simplicity, it is assumed 
that all effects of the capture biomolecule’s charge are incorporated into no and that σ is 
only the change in effective surface charge as a result of the captured biomarker. This 
treatment only holds true in the linear region of operation and not in sub-threshold or 
saturation. A treatment of the exponential response in the sub-threshold region and the 
challenges associated with operation of a SiNW sensor in this region and real-world 
considerations associated with operation in the saturation region are given in Chapter 2. 
 In this first principles calculation, the change in the current flowing through the 
channel in a SiNW biosensor is purely the result of the change in surface charge density 
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or, more specifically, the change in the effective surface charge imparted by captured or 
proximal biomarkers. In discussions in subsequent chapters, Idrift,net will simply be 
referred to as ID – the measured drain current. 
1.5 High-Level Design Considerations 
 In designing and using a charge based sensor, we have some fundamental 
considerations and some practical considerations. Let us look at considerations regarding 
the SiNW itself. In designing the SiNW, sensitivity should be maximized. Sensitivity, S, is 
simply the change in current for a given σ: 
 
  
       
      
 
         
        
 
(1.7) 
 Clearly either the denominator must be minimized or the numerator maximized 
to maximize sensitivity. σ is determined by the biomarker and cannot be changed. q is a 
fundamental constant and also cannot be changed. no can be lowered by using a lower 
doping density. Limits on the minimum measurable ID at a given VDS impose some lower 
doping threshold, but in general, lower doping densities are preferred. Also, we notice 
that decreasing h and w, that is making the SiNW cross-section smaller, also improves 
sensitivity. Process limitations might introduce undesired effects such as surface 
roughness that begin to degrade performance, but again, in general, smaller cross-section 
SiNWs are preferred. Initial experiments in scaling placed a lower limit on SiNW width – 
again something discussed in Chapter 2. 
 These points combined do touch upon a key practical difference between top-
down and bottom-up fabrication of SiNWs. Controlling process parameters such as 
SiNW doping concentration and dimensions are critical for consistent sensitivity. 
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Bottom-up grown SiNW biosensors have substantial variances in device-to-device 
performance because of their inherent lack of control in processing. [26] Top-down 
SiNW biosensors have fared substantially better because of their basis on tried and true 
CMOS compatible materials and workflows. [29] It is for this reason that this work 
centers on a CMOS compatible top-down fabrication process.  
 The primary reason for making a distinction between the charge of a biomolecule 
and the effective surface charge in earlier discussions is because of Debye screening. In 
any ionic solution, ions in the solution will screen all the charge of a biomolecule given a 
sufficient distance. This distance is known as the Debye length, λD, and is described by 
the following formula: [39] 
 
   
 
                 
 
(1.8) 
Where lB is the Bjerrum length (nm), ρi is the density of each type of constituent ion 
(q/nm3), and zi is the valency of each constituent ion (dimensionless). lB accounts for the 
permittivity and temperature of the solution as well as the Boltzmann constant and 
elementary charge. For water based solutions at 300 K, lB is ≈0.7 nm. [39] 
 The Debye length is of importance because in a sufficiently strong ionic solution, 
much of the charge of a captured biomarker will be screened before it can have any 
effect on σ and therefore, ID, Conversely, in a sufficiently weak ionic solution, spurious 
charges from biomarkers in solution that are not actually bound to the capture 
biomolecule will result in erroneous changes in ID. [38, 39] Selection of a specific ionic 
strength for the buffer solution, which in turn determines a specific λD, is dependent on 
a number of factors including the charge and size of the biomarker. As such, specific 
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discussions of ideal PBS concentrations will be made in Chapters 3 and 4, which deal 
specifically with biosensing. 
 The surface potential effected by a charge for a given bulk and surface proton 
concentration is given by the Nernst equation: [40] 
 
  
    
 
    
      
         
  
(1.9) 
Where kB is the Boltzmann constant (eV/K), T is the temperature (K) and the H
+s are 
the bulk and surface proton concentrations (q/cm3). It follows from this that the 
maximum change in surface charge for a given change in pH (or put another way, a 
logarithmic or ten-fold change in proton concentration) is: [40] 
 
       
    
 
        
(1.10) 
Which at 300 K equates to 59 mV/pH; this being the classically fundamental limit on the 
sensitivity of an ion-gated FET. The discussion of the Nernst limit is purely academic for 
the purposes of this work because the fabricated devices are limited more by the SiNW 
cross-sectional area and doping concentration, which combined do not allow complete 
modulation of carriers through the entire SiNW. [41] 
1.6 High-Level Usability Considerations 
 While performance is a fundamental consideration, usability is a practical one.  A 
new platform should only require minimal changes in assay workflows for clinicians and 
researchers. It should also be low-cost. Conceptually, an ideal starting point is to view 
this new platform as a highly scaled version of the most ubiquitous of current platforms, 
the conventional microplate. [42] 
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 To better understand the rationale for using a microplate as the basis, we can 
look at an alternative approach for sample delivery, microfluidics; an area that has 
received a fair amount of attention. [43] Elaborate on-chip routing of fluids has been 
demonstrated. [44] On-chip micofluidics, however, come with several drawbacks. They 
increase the cost and complexity of the chip and also require off-chip control elements 
such as pumps. [44, 45] However, most important is the issue of fluid flow in 
increasingly narrow microfluidic channels. As flow starts to become diffusion dominated, 
delivering analyte to individual sensors becomes exceedingly prohibitive in terms of both 
time and sensitivity. [46] The flux of analyte molecules in microfluidic systems decreases 
dramatically compared to macro-scale alternatives and in fact places a practical lower 
limit around femtomolar sensitivities even for fluidic channels hundreds of microns 
wide. [47] For these reasons, the logical solution is to turn to spotting individual wells in 
a manner similar to how protein microarrays are spotted – and something that is also a 
scaled analog of the micropipettes used to load conventional microplates . [19] Isolated 
wells can also be lithographically defined and the fabrication of an electronic microplate 
using wells remains CMOS compatible, something that would not be the case with 
microfluidics. Such a solution could also potentially be used in flow-through systems if 
the application arises. 
1.7 The Electronic Microplate 
 Vital to the realization of the electronic microplate is coalescence of a number of 
technologies. Many of these concepts have been previously demonstrated piecemeal. For 
example, arrayed SiNWs made with bottom-up processes have been used to detect 
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conventional cancer markers. [48] However, this has not been accomplished with a top-
down fabrication process. CMOS compatible SiNW biosensors have been demonstrated, 
but not in an arrayed fashion. [29] This work aims to develop both new applications and 
certain enabling technologies for a platform that best leverages an electronic label-free 




Figure 1.7: The electronic microplate in an example 3 x 3 configuration 
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 The electronic microplate can be described as a modern, label-free, high-density, 
and electronic reincarnation of the ubiquitous and five decade old conventional 
microplate. In this sense, the electronic microplate consists of individual isolated wells, 
each containing a SiNW sensor. These sensors are individually addressable and therefore 
capable of concurrently performing multiple assays.  
 This approach maximizes the usability of the platform. However, there is another 
key piece of technology necessary to truly enable a platform with broad utility as the 
electronic microplate should be low-cost and disposable. This requires a separation of 
the electronic microplate or sensing layer from the sensing electronics or electronics 
layer and linking the two via temporary compliant interconnects. Three-dimensional 
stacking (3DS) technologies, in particular the use of through-silicon vias (TSVs), can be 
used to electrically connect the wet sensing side of the sensing layer to the dry interface 
side and compliant interconnects to mate the dry side interface side of the sensing layer 
with the electronics layer. [49, 50] 
 A number of direct and indirect advantages are the result. First, costly sensing 
electronics can be reused, lowering the cost of the disposable portion. Second, routing 
the signals directly to the backside allows for exceptionally high sensor densities. Third, 
the wet sensing side is delineated from the sensing electronics. Fourth, usage of the chip 
remains very much in line with existing clinical workflows. Fifth, chips with a broad 
range of capabilities including heaters for polymerase chain reactions and SiNWs for 
biomarker detection can potentially be interchangeable. In the spirit of systems biology, 
these advantages could combine to create tremendous potential for widespread 
applications ranging from point-of-care diagnostics to fundamental research. [51, 52] 
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1.8 Overview of the Presented Research 
 The electronic microplate is a coherent concept, but requires the combination of 
many technologies across many fields. While the idea is in its infancy, the purpose of this 
work is two-fold: demonstrate new label-free sensing methodologies that when 
combined with previously demonstrated methodologies can add to the modern 
diagnostic toolkit and demonstrate a promising scaling path forward that can ultimately 
enable ubiquitous screening for countless biomarkers. To that end, it focuses on the 
sensing layer of the platform and assays that can be performed on it. 
 This dissertation focuses on two main areas: new biosensing applications for 
SiNW sensor arrays and scaling SiNW sensor arrays. The associated work is divided into 
four chapters. The first of these, Chapter 2, discusses the development of a baseline 
workflow for the fabrication of SiNW sensors and measurement methodologies 
congruent with non-planar CMOS fabrication – neither of which existed prior in the 
facilities used for this work. The next three chapters discuss new sensing methodologies 
and scaling. Chapter 3 discusses using a fully top-down fabricated SiNW sensor array 
with integrated wells to delineate between cancerous and non-cancerous cells using their 
intracellular contents. [53] Chapter 4 discusses using this same array to sense the 
presence of superparamagnetic particles in solution. [54] Then Chapter 5 discusses the 
use of TSVs to dramatically increase SiNW sensor densities in a truly scalable manner. 
[55] A final chapter wraps up with the contributions of this work and points out the 
logical next steps and areas of collaboration necessary to implement the electronic 
microplate concept as a next-generation biosensing platform.  
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2 SiNW CONSIDERATIONS AND PROCESS DEVELOPMENT 
 
2.1 Background 
 The initial priorities of the presented research were to establish a baseline SiNW 
fabrication workflow and a set of measurement parameters. Working from the ground up 
with both applications and scaling in mind painted a picture where fabrication and 
measurement considerations were the initial drivers.  
This chapter discusses three topics. The first topic discusses the design and 
fabrication of the SiNW test devices that formed the basis for all subsequent testing in 
this work. The second topic summarizes the considerations that went into how the 
electrical measurements were performed. The third topic recounts the electrical 
characterization of these devices in dry and wet conditions. 
2.2 Process Development 
 The first step in the process development was to create a highly anisotropic etch 
that could define the nanometer scale features required for the SiNWs. This eliminated 
wet etches such as those using TMAH which etch different crystal planes at greatly 
different rates. [56] Attention logically turned to using a dry inductively couple plasma 
(ICP) based process. [57] Test patterns consisting of 100 nm, 50 nm, 25 nm, and 15 nm 
lines were patterned with electron-beam lithography (EBL), (JEOL JBX-9300FX), using 
hydrogen silsequioxane (HSQ) resist (Dow Chemical) on silicon-on-insulator (SOI) 
wafers (SOITEC) with a 70 nm thick device layer (p-type, 1-10 Ω-cm), a 145 nm buried 
oxide (BOX) layer, and a 500 μm handle layer. The test pattern is shown in Figure 2.1. 
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Figure 2.1: High-contrast optical image of the SiNW test pattern 
The pattern is HSQ on Si. The lines are 100, 50, 25, and 15 nm in width from left to 
right and from bottom to top. The 15 nm lines are not visible due to the resolving limits 
of the microscope. The larger features at the top right were used to study EBL proximity 
effects. The scale bar is 10 µm. 
 
 The device layer was etched with an Ar/Cl2 ICP (STS SOE) to the BOX, thereby 
forming the SiNWs. Testing indicated that the ICP process had a Si:HSQ etch selectivity 
of 3.69:1 nm/s (see Appendix Table 7.1). With a 70 nm device layer, the minimum HSQ 
thickness could only be approximately 19 nm and still suffice as an etch mask. In theory, 
this should have allowed for patterning 25 nm lines and perhaps even 15 nm lines 
without isotropy or over-etching with the thickness dependent resolution of HSQ. [58] 
However, real-world conditions were not quite so accommodating and 50 nm became 
the ideal reliably definable SiNW width. The three narrowest widths fabricated are 
shown in Figure 2.2. 
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A     B 
C  
Figure 2.2: Three-quarter views of SiNWs of varying widths 
The widths are 15 nm (A), 25 nm (B), and 50 nm (C). Note the decrease in anisotropy at 
25 nm and 15 nm and the significant over-etching at 15 nm. 
 
A     B  
Figure 2.3: Complete SiNW with contact pads for metal electrodes 









 All subsequently described work used a SiNW of the geometry shown in Figure 
2.3, but of either longer or shorter channel lengths. A false color SEM in Figure 2.4 
highlights this typical SiNW.  
 
 
Figure 2.4: Three-quarter view false-color SEM of one end of a SiNW 
 
 Multiple electrode configurations were also tested but the high-yield of the 
SiNWs ultimately enabled the longest test length of 25 µm with a common source 
electrode to be used. This allowed a large effective sensing area due to the length and 
more SiNWs to be fabricated in a given area due to the shared source electrode. Optical 
lithography (Karl Suss MA-6) defined the electrodes. E-beam evaporated (CVC) Ni was 
initially used for the electrodes because of some promising then-current work on 
forming low-resistance NiSi alloys. [59] However, poor reliability with Ni, discussed later 
in this chapter, resulted in a switch to a more conventional choice of e-beam evaporated 
Al for the electrodes. [27] Following metallization and lift-off, a 400 ˚C rapid thermal 
process (RTP), (AET RTP) anneal in forming gas created ohmic contacts between the 
 27 
electrodes and the SiNWs. Some of the electrode test configurations are shown in Figure 
2.5. 
 
A    B  
Figure 2.5: Top-down views of two electrode configurations 
Configuration (A) has dedicated source and drain electrodes for each SiNW, whereas 
configuration (B) has a common source “rail” electrode for all SiNWs. Both 
configurations have two channel lengths of 5 and 25 µm. (B) was the final test 
configuration used for measurements. 
 
 NR9-1500PY photoresist (Futurrex) was initially used to protect the electrodes 
and form a well for wet measurements. However, this was later switched to SU-8 
(Microchem), again for reliability reasons. 
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Individual source and drain 
electrodes 
 







A   B  
Figure 2.6: Images of a fabricated test chip 
The well is 20 x 500 µm. 
 
2.3 Measurement Considerations 
There were two primary considerations for electrical measurements. The first 
choice was between AC or DC measurements and the second choice was in the region of 
operation. AC sensing measurements almost universally use a lock-in amplifier while DC 
measurements can be performed with a combination of DC sources and greatly 
simplified with the source measure units found in semiconductor parameter analyzers. 
They both generally yield similar performance. [29, 34, 60, 61] DC measurements using 
parameter analyzers were chosen for this work for a few reasons. First, this is identical to 
how a FET is characterized and operated. Second, all the biasing including the back-
gating could be performed with one unit. Third, additional properties including leakage 
currents and transconductance could be extracted from one set of data, greatly aiding 
characterization and troubleshooting of the devices. The basis for selecting DC biasing 










The choice of the mode of operation or biasing region was purely driven by 
technical considerations. The carrier screening length in Si, the length at which a single 
surface charge is screened by the bulk semiconductor, λSi, is ≈20 nm at the carrier 
concentrations in the wafers used in this work. [62] In the sub-threshold region, where 
λSi is larger than the cross-sectional dimensions of the device, the carrier density is, to 
first principles, defined by Fermi-Dirac statistics. [61, 62] Thus:  
 
       
     
    
  
(2.1) 
Where EF is the Fermi level (eV), Ei is the intrinsic Fermi level (eV) and ni is the intrinsic 
doping concentration (electrons/cm3).A change in carrier density is therefore related to a 
change in surface potential, φ (V), by: 
 
       
    
    
  
(2.2) 
It then follows that ID is exponentially proportional to the surface charge: [63] 
     
  (2.3) 
 Ideally, this would imply a great mode of operation for a high-sensitivity sensor – 
one where linear changes in surface charge result in exponential changes in carrier 
density and drive current. However, currents in the sub-threshold region are also at least 
two or three orders of magnitude lower than those in the linear region for most types of 
charge based sensors, even carbon nanotubes. [64] This in turn places a higher burden 
measurement apparatus and unfortunately a noise burden that was too high to reliably 
overcome with the available measurement setup.  
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There is also an upper bound on our biasing region. In saturation, ID has a 
quadratic dependence on surface charge: [63] 
     
  (2.4) 
However, the VDS biasing potentials required for getting into saturation are too large for 
a biosensor and result in spurious current paths along the surface of the SiNW from the 
source to drain. [65] In fact, initial devices operated in saturation often failed. 
The chosen linear region was the most pragmatic compromise between a 
sufficiently high ID, one that is far more reliably measureable, and a low VDS. The surface 
charge to current relationship here, and as previously described in Chapter 1, is: [63] 
      (2.5) 
 It is important to note here that in an accumulation mode SiNW sensor, the 
colloquial definition of threshold voltage is similar to that of an inversion mode FET, 
but it is physically different. In an inversion mode FET, the threshold voltage is the 
point at which an inversion channel completely links source and drain and minority 
carriers become the dominant source of channel conduction. In an accumulation mode 
SiNW sensor, the threshold voltage is generally considered the point at which the VG/ID 
relationship becomes fully linear as there is no inversion channel. [61, 65-67] The linear 
region in this definition for an accumulation mode test device is shown in Figure 2.7. 
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Figure 2.7: The linear region for a process development device 
The linear region is indicated by the red line from ≈-30 to -40 VGS at -5 VDS. 
 
2.4 Dry Measurements 
 All measurements described in this work were performed in a mechanically 
isolated and electrically shielded Cascade enclosure with a Cascade 
Alessi/Micromanipulator probestation and probes. The source and drain electrodes were 
contacted via tungsten probes and the back-gate via the chuck. A HP/Agilent 4156A 
semiconductor parameter analyzer with four independent source-measure units was used 
to perform all the measurements. The measurement setups specific to each test are 
shown in their appropriate chapters. 
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 Source, drain, and gate bias polarity and current direction definitions as used 
throughout this work are shown in Figure 2.8 and follow conventional FET semantics 
with the BOX and carrier layer serving as the field oxide and back-gate, respectively, and 













Figure 2.8: General biasing configuration and terminal polarities 
 
 A typical set of dry transfer curves for a 25 µm long SiNW test device is shown in 
Figure 2.9. VGS was swept from 0 to -50 V in increments of -10 V. 
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Figure 2.9: Dry IV curves for a process development device 
 
2.5 Wet Measurements 
 After establishing a satisfactory fabrication workflow and verifying the basic 
operation of the SiNW devices, attention turned to testing in the PBS ambient that 
would be applicable for the experiments of Chapters 3-5. Initial wet measurements 
centered purely on testing the survivability of the devices in pH 7.6 PBS. Samples were 
manually loaded into cell cloning cylinders (Dow Corning) with a micropipetter as shown 
in Figure 2.10. 
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A     B  
Figure 2.10: Testing setup for preliminary testing 
 
 At the beginning, the devices were plagued with extremely poor reliability in PBS. 
An inspection of the transfer curves and SEM and optical images of failed devices 
revealed one of two things in these devices. Invariably, the SiNW itself failed leading to 
an open circuit or the drain shunted to the source. The former case of SiNW failure was 
the result of large VDS biases in the saturation region in PBS – a driver behind why 
devices were thereafter operated in the linear region. 
 
 
Figure 2.11: Bias induced damage of a SiNW 
Note the break in the middle. 
 













 The latter case of a drain to source shunt was actually the result of two different 
and independent causes. The most common cause was inadequate passivation of the 
electrodes which allowed the solution to penetrate the boundaries of the well.  This was 
resolved with the previously mentioned two-fold solution. First, the electrode metal was 
changed from Ni to Al and the photoresist defining the wells was changed from the 
organic polymer based NR9-1500PY to a hard-baked epoxy based SU-8.  
 
 
Figure 2.12: Passivation failure in a test device 
Note the damage to the common source electrode and the biased center-left drain 
electrode. 
 
 Poor surface passivation of the SiNWs was the other contributor to an undesired 
current channel between drain and source through the PBS. High-temperature annealing 
of non-planar FET devices in both O2 and H2/N2 has been shown to improve device 
performance, primarily by reducing etch induced damage and to also form a thin 
insulating SiO2 or SiN layer on the SiNW surface. [69, 70] A two minute 900°C RTP in 
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O2 was added after the ICP etch to accomplish both of these functions. The drive 
current increase is shown in Figure 2.13.  

























Figure 2.13: Dry IV curves before and after oxygen annealing 
The black curves are 50 nm and the red curves are 100 nm SiNWs. VGS was –20 V. 
 
 The O2 anneal also reduced leakage between the SiNW and the solution because 
of the formation of ≈3 nm of SiO2 on the SiNW surface, a fact even more relevant for a 
sensing application. SiNW to solution leakage measurements involved a unique 
configuration that used an Ag/AgCl electrode held in a well as shown in Figure 2.14. A 
voltage sweep of VDS with a grounded Ag/AgCl electrode in PBS confirmed the 
improvement in SiNW passivation as measured by both the hysteresis and leakage 
current magnitudes, the former of which is often a result of surface states on Si. [71] 
 37 
A     B  
Figure 2.14: Testing setup for leakage testing 
 























Figure 2.15: SiNW to PBS leakage currents before and after oxygen annealing 
VGS was held at 0 V. 
  
Ag/AgCl electrode 












 Fortuitously, this annealing not only resolved the leakage issues and improved 
device performance, but also brought the workflow closer in step with non-planar 
CMOS fabrication. [70] A detailed look at the entire workflow is presented in the 
Appendix in Table 7.2. 
 For preliminary device sensing characterization in biologically relevant solutions, 
a test sensor was first used to perform pH sensing, one of the canonical tests of charge-
based sensors.  The relative concentration of H+ and OH- ions in a buffer solution 
results in the protonation or deprotonation of the terminal Si–OH groups on the SiNW, 
thereby altering the surface potential on the SiNW and consequently the channel 
conductance. [72] PBS at pH values of 2.8, 7.6, and 12.3 was used. Figure 2.16 shows the 
response of a SiNW sensor to these three buffers Biasing was -5 VDS and -8 VGS. 



















Figure 2.16: Time-dependent response to varying pH solutions 
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 As expected, the more basic pH 12.8 buffer with an abundance of negatively 
charged OH- ions increased the magnitude of the drain current. Conversely, the more 
acidic pH 2.8 buffer with an abundance of positively charged H+ ions decreased the 
magnitude of the drain current. The hysteresis is due to the well configuration which 
required the previous sample to be drawn out before the next one was introduced.  
2.6 Summary 
 This chapter discussed the considerations that went into establishing both 
fabrication and measurement baselines used in the subsequent work.  The electrical 
measurement setup was defined by technical limitations of the measurement equipment, 
namely the minimum measureable currents which dictated operation in the linear region. 
The fabrication workflow was defined by process limitations, performance 
considerations, and efforts to mitigate device failure. Dry and wet measurements 
confirmed the ability of these baselines to enable a simple and effective SiNW sensing 
setup compatible with standard both CMOS fabrication and FET measurements.  
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3 CELL-LINE SENSING WITH A LOW-DENSITY ARRAY 
 
3.1 Background 
While simply using SiNW sensors, or any other label-free scheme in isolation does 
leverage certain advantages, such as reducing processing steps compared to labeled 
schemes, there are far more substantial advantages to be had with a chip featuring 
multiple arrayed sensors fabricated using a workflow that is harmonious with modern, 
non-planar, IC fabrication methods. [48, 73]  
This chapter discusses two main topics. The first is the top-down fabrication of a 
SiNW array with 16 sensors in isolated polymer wells – an early step towards the 
electronic microplate. The second is a practical use of this sensor array for a new type of 
differentiation method between cancerous and non-cancerous ovarian epithelial cell-
lines. [74]  
3.2 Cell-Line Low-Density Array Fabrication 
The SiNW array fabrication process closely followed the baseline process 
described in Chapter 2. It began with a SOI wafer with a 70 nm thick device layer (p-
type, 1-10 Ω-cm), a 145 nm BOX layer, and a 500 μm handle layer. EBL was used to 
define a 4 x 4 array of 50 nm wide x 70 nm tall x 50 µm long SiNWs per 1 x 1 cm chip. It 
is important to note that this relatively low density of sensors was chosen not because of 
any inherent process or design limitations, but to facilitate simple manual sample 
spotting via micropipettes for the tests reported in this chapter. A flow-through system 
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was used for the tests reported in Chapters 4 and 5. Chapter 5 goes on to describe how 
this sensor density was scaled by approximately three orders of magnitude. 
Following EBL, the device layer was anisotropically etched down to the BOX 
using the same Ar/Cl2 plasma process in an ICP, which in turn formed the SiNWs. The 
sample then underwent a 900 ˚C RTP anneal in an O2 ambient. Optical lithography was 
then used to define the Al source and drain electrodes which were subsequently 
deposited using e-beam evaporation. After lift-off, a 450 ˚C RTP anneal in forming gas 
created ohmic contacts between the Al electrodes and SiNWs, with the slightly increased 
temperature producing more reliable contacts. To protect the electrodes and define the 
wells, two layers of SU-8 epoxy based photoresist were deposited. The first 2 µm thick 
layer protected the electrodes and opened up 40 x 40 µm windows around the SiNWs 
and the probing pads while the second 100 µm thick layer formed the 1 mm diameter 
wells into which the samples were loaded. An overview of this workflow is shown in 
Figure 3.1 and images of a completed SiNW array in Figure 3.3. Again, a more detailed 
look at the processing steps is given in the Appendix in Table 7.3. 
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A     B  
C     D  
Figure 3.1: Depiction of the low-density array processing workflow 
For simplicity, only one well is shown. The SiNW was first defined on the device side of 
the SOI wafer (A) followed by electrode formation (B). Next, the electrodes were 
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Figure 3.2: CAD layout of a single low density chip 
A close-up of two sensors is shown. 
 
A    B  
C  
Figure 3.3: Images of a fabricated low-density array chip. 
Shown are a 1 x 1 cm, 4 x 4 array (A), an individual 1 mm diameter well (B), and the 40 x 
40 µm window revealing the 50 nm x 70 nm x 50 µm SiNW 
 




































3.3 Characterization Measurements 
The devices were again operated as accumulation mode, back-gated transistors in 
the linear region. Measurements were made in dry and wet conditions. Standard ID vs. 
VDS curves from initial dry measurements are shown in Figure 3.4. 




















Figure 3.4: Dry IV curves for a low-density array 
The red circle indicates the -5 VDS biasing point used in sensing experiments. 
 
 Figure 3.5 shows the average and ± two standard deviation ID for all 16 sensors 
in one array. The sensors actually used for the sensing experiments fell within even 
tighter tolerances, less than ± 5 %, of each other. 
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Figure 3.5: Average and ± two standard deviation ID for 16 sensors in an array 
Again, the red circle indicates the -5 V biasing point used in sensing experiments. 
 
Next began wet measurements and characterization. ID vs. VGS curves were first 
measured. These curves were then used to determine the peak transconductance point in 
the linear region at VDS = -5 V and that biasing point was then used for all wet sensing 
measurements. In all subsequent discussions, the standard definition of 
transconductance, gm, is used and calculated internally by the measurement tool: 
 
   
   
    
 
(3.1) 
The peak back-gated gm in pH 7.6 PBS was typically around 0.2 µS and occurs 
near VGS = -20 V. Typical ID and gm vs. VGS curves are shown in Figure 3.6. 
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Figure 3.6: Wet ID and gm vs. VGS curves in pH 7.6 PBS for a low-density array 
 
There are two noteworthy points to be made about wet measurements. The first 
is that gate biasing was provided by the back-gate during transconductance 
measurements, and therefore would only be expected to be an approximate indication of 
the optimal gate bias for biochemical sensing, which occurs as the result of surface 
charge changes on the sides and top of the SiNW. However, previous work has shown 
back-gate biased transconductance to be an effective gauge of sensing performance. The 
second is a roughly factor of two reduction in ID in PBS compared to the dry conditions. 
The same previous work has indicated that this reduction is the result of a PBS/SiO2 
equilibrium resulting in a net positive change in surface charge. Both points are discussed 
in greater detail in the prior work. [65] 
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3.4 Arrayed Cell-Line Sensing 
The first of the two new applications for a label-free sensor discussed here is the 
differentiation of two cell lines. The second application, detection of paramagnetic 
particles, is discussed in Chapter 4.  
While pH sensing was initially used to test the fabrication process and the 
measurement setup in the development stages, the ultimate objective of the low-density 
sensor array was not to recreate a pH meter. Rather, the objective of the low-density 
array was to develop new biological sensing applications for a SiNW sensor. To this end, 
a new method for differentiating between two human ovarian cell lines was developed 
that fundamentally differs from prior methods that have traditionally relied on genetics 
or proteomics for differentiation. [75-77] The first of these cell lines, immortalized 
ovarian surface epithelial (IOSE), was an immortalized cell line that consisted of healthy 
epithelial ovarian cells. The second, human ovarian carcinoma (HEY), was a cell line that 
consisted of cancerous epithelial ovarian cells. Working under the hypothesis that the 
contents and makeup of the two cell lines should differ due to the more aggressive 
proliferation demands of the cancerous HEY cells, samples were made containing the 
contents of these cells at specific concentrations.  
Because sensing was of the intracellular contents which do not bind directly to 
any receptor on the surface of the SiNWs, a large Debye length was preferred. [39] This 
is quite similar to the detection of ions in solution with SiNW sensors. [26, 78] Following 
from the discussion in Chapter 1 and using Equation 1.8, 1x PBS has a λD of 0.7 nm, 
0.1x PBS of 2.3 nm, and 0.01x PBS of 7.3 nm. The large screening length of 0.01x PBS 
was chosen for these measurements to maximize the effects of the charges in solution.  
 48 
For the tests in this chapter, a micropipette was used to both introduce and 
withdraw ≈10 µL of solution in to and out of the hydrophobic SU-8 wells.  The 
micropipette tips were changed between solutions. The testing setup is shown in Figure 
3.7. Also, the t = 0 s point started after ≈100 s after pH 7.6 PBS had first been 
introduced into the well to allow stabilization of ID. 
 
A     B  
Figure 3.7: Testing setup for arrayed cell line sensing 
 
At the highest concentration, two samples were made, each with the contents of 
750,000 cells from either the IOSE or HEY cell lines per 1 mL of pH 7.6 PBS. These 
two samples were then serially diluted into concentrations of 75,000 cells/mL PBS and 
7,500 cells/mL PBS. 
Five sensors from a single 4 x 4 array were then used to run identical tests. The 
tests consisted of switching between the HEY and IOSE samples at all three 
concentrations. Each sample was left on the chip for approximately 100 s. A time-
dependent plot from one of these five tests is shown in Figure 3.8. 









































Figure 3.8: Time-dependent response to HEY and IOSE solutions 
 
 The solutions were introduced, alternating between HEY and IOSE, and 
progressively from 750,000 cells/mL down to 7,500 cells/mL. The quantitative change 
in ID for these five sensors is shown in Figure 3.9 as the percentage change in ID between 
the two cell lines. 
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Figure 3.9: Percentage difference in ID between HEY and IOSE 
The black squares are the mean, the red circles the minimum, and the green triangles the 
maximum change in ID for the five sensors on a single low-density array at each of the 
three concentrations. 
 
 A number of observations can be made from these tests. The ID magnitude is 
greater for the HEY sample than it is for the IOSE sample. The pH values of the 
samples’ buffer solutions were identical. Thus, the change in current does not occur 
because of the protonation or deprotonation of the Si-O-/Si-OH groups on the SiNW 
field oxide as was the case in the previous pH tests. The HEY sample must therefore 
contain more negative charge (or less positive charge) than the IOSE sample because of 
the larger HEY ID magnitude. The most plausible explanation is the difference in the 
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intracellular ion concentrations between the two cell lines. This is supported by the fact 
that a number of positively charged metal ions (namely Mnn+ and Fen+) have been 
reported to be found in substantially lower concentrations (a factor of 24 and 4 
respectively) in cancerous cells as compared to their healthy equivalents. [53, 79]  
 Rewriting Equation 1.7 in terms of surface charge density yields: 
  
                
              
 
(3.2) 
Solving this equation for a 50 x 75 nm SiNW with a doping density of 2·10 15 holes/cm3, 
the following mean changes in surface charge densities are obtained: 
 














With a 7.3 nm screening length, the changes in volume charge density approximate to: 
 














 This data offers a unique measurement showing the difference in effective 
volume charge between two cell lines. Using a concentration of 7,500 cells/mL (where 
self-screening would be minimal) the change in charge associated with an individual cell 
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is 0.658 statC/cell, which in turn amounts to a change of 1.37·109 units of elementary 
charge between the intracellular contents of a HEY and IOSE cell. This presents an 
interesting reference point for future work as no previous comparative data exists. 
 Since the ions in the HEY and IOSE solutions are also not expected to directly 
protonate or deprotonate the Si-O-/Si-OH surface groups on the SiNW and the PBS can 
be expected to maintain a constant proton concentration. The modulation, therefore, 
arises simply from the close proximity of ionic charges in the solution to the conducting 
channel in the SiNW. [78] Some indications of this are that the signal to noise ratio 
(defined as µ/σ) is roughly three times higher for the cancer cell tests than the pH tests 
and there is very little hysteresis between sample exchanges, even with a manual spotting 
setup, indicating there are no actual binding/unbinding events at the SiNW surface. 
 To confirm the statistical significance of the difference between the HEY and 
IOSE current values, a two-tailed, unpaired t-test is performed on all the tests to obtain 
the associated p-values. To avoid noise associated with the sample exchanges, only ID 
values from the middle 50 s for each sample are used. From this data, it can be 
concluded that down to a concentration of 75,000 cells/mL, all five sensors yielded 
statistically significant (p < 0.05) results. Table 3.3 lists the resulting p-values. 
 





   Sensor   
cells/mL 1 2 3 4 5 
750,000 < .001 < .001 < .001 < .001 < .001 
75,000 < .001 < .001 < .001 < .001 < .001 
7,500 0.216 < .001 0.059 0.021 0.010 
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Interestingly, in Figure 3.9, there is a log-linear relationship between the cell 
concentration and change in current. Such log-linear behavior has been previously 
reported for SiNW sensing of several molecules and ions ranging from purified cancer 
markers like prostate specific antigen to pH measurements. [80, 81] More quantitative 
treatments have attributed this to increased partial screening between the species 
themselves in solution; that is, an increased concentration of species, be they ions or 
macromolecules, will partially offset the increased charge resulting from that increased 
concentration. [37, 38] 
3.5 Summary 
 This chapter discussed the development of a top-down fabricated SiNW sensor 
array with wells that could be individually spotted and a new application for a charge 
based sensor. It was also demonstrated that cancerous and healthy ovarian epithelial cells 
could be differentiated purely based on a difference in charge between their intracellular 
contents and that this difference was statistically significant at the concentrations tested 
across multiple sensors on an array. 
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4 SPION SENSING WITH A LOW-DENSITY ARRAY 
 
4.1 Background 
 An exciting recent development in cancer research has been the use of 
superparamagnetic iron-oxide nanoparticles (SPIONs) for the capture of circulating 
cancerous cells, both as a diagnostic and therapeutic tool. However, here again, sensing 
capture events resort to labeled methods. This presents another application for a SiNW 
sensor array, this time to detect circulating functionalized SPIONs. 
 This chapter discusses one primary topic. A SiNW sensor used to detect 
circulating superparamagnetic particles functionalized with biomolecules in the presence 
of an electromagnetic field. 
4.2 SPION Low-Density Array Fabrication 
 The fabrication process and the resulting array were identical to the one 
described in Chapter 3. Demonstrated robustness of the process and the resulting 
devices was the key factor in reusing this array. 
4.3 Superparamagnetism 
 Magnetic materials fall into a few general categories, of which two are of note 
here. Ferromagnetic materials have a permanent magnetic moment and therefore 
produce a permanent magnetic field. Paramagnetic materials on the other hand only 
achieve a net magnetic moment in the presence of an externally applied magnetic field. 
In the special case of superparamagnetism, particles at sufficiently small sizes can form a 
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single and coherent magnetic domain – unlike ferromagnetism and conventional 
paramagnetism where there is only a net difference in electron spins. This leads 
superparamagnetic particles to be strongly influenced in the presence of magnetic fields, 
but to also become non-magnetic in the absence of magnetic fields. [82] This property 
has already been leveraged in medicine, particularly in magnetic resonance imaging and 
for the extraction of tagged tumor both in vitro and in vivo cells, but has not been 
previously used for direct sensing. [54, 83] 
4.4 Functionalized SPION Sensing 
 The particles used in this work were Fe3O4. A depiction of such particles in one 
of the most basic functionalization schemes with amine and carboxyl groups is shown in 
Figure 4.1 as a conceptual analogy to the amino acids in Figure 1.3 – actual testing was 
performed with a protein functionalization. 
 
 




For this test, 1x PBS at pH 7.6 with a λD of 0.7 nm was chosen to best mitigate 
the effects of any SPIONs in solution not actually attracted to the sensor surface  by the 
magnetic field. The starting point was a solution of SPIONs 1 µm in diameter and 
functionalized with strepomyces acdinii bacteria derived strepavidin in PBS (Sigma-Aldrich) 
at a concentration of 1.0 mg/mL. This solution was then serially diluted into 
concentrations of 0.1 and 0.01 mg/mL. Strepavidin is a negatively charged protein at a 
pH of 7.6. [29] 
The flow-through setup used a small reservoir, tubing (Tygon), and a peristaltic 
pump (VWR) operating at a flow rate of 10 mL/min, quite similar to the setups used for 
the extraction of circulating tumor cells in therapeutic applications. [54] The inlet and 
outlet tubing entered a 2 mm diameter x 4 mm tall cell cloning cylinder which was 
capped and sealed with mounting adhesive (Crystalbond).  
 
A     B  
Figure 4.2: Testing setup for SPION sensing 
The magnetic chuck is simply a coaxial electromagnet with an Al plate affixed on top. As 
the vacuum and biasing of the probestation chuck could not be used, double-sided Cu 
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Source probe               Drain probe 





















tape was used to secure the sample. The electromagnet displayed effectively no hysteresis 
at the testing sampling time of 1 s. 


































Figure 4.3: Time dependent response for a 1 mg/mL SPION solution 
The electromagnet was switched on and off manually, so the plotted timing of the 
magnetic field is only approximate. 
  
 The flow-through configuration combined with the SPIONs only being detected 
by charge proximity to the SiNW and not by an actual interaction with the SiO 2 surface 
groups allowed for lower hysteresis during solution exchanges than the configuration of 
Chapter 2 used for pH measurements. Interestingly, there is actually more noise when 
the magnet is off. A plausible explanation is that when the magnet is on, the SPIONs are 
actively held at the sensor surface, whereas with the magnet off, there is likely influence 
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from the SPIONs merely flowing through near the sensor surface below the short, but 
non-negligible, screening length, as is the case with the sensing of other biomolecules. 
[39]  
 To verify that the electromagnetic fields themselves were not resulting in the 
change in ID through any number of mechanisms such as Eddy currents or the Hall 
effect, however unlikely, a test was performed with just the PBS solution cycled through, 
but with the electromagnet switched on and off as before. The result validated that the 
change in current does in fact arise from the magnetic field-induced capture of the 
SPIONs as per Figure 4.4. 


































Figure 4.4: Time dependent response for a control solution without SPIONs 
The electromagnet was again switched on and off manually, so the plotted timing of the 
magnetic field is only approximate.   
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 An associated time constant, τ, can be extrapolated from a fit that describes the 
rise of ID over time – quite similar to the RC time constant in a passive electronic circuit: 





The extrapolated time constants for three different SPION concentrations of 1, 0.1, and 



















Figure 4.5: Relationship of the rising time constant with SPION concentration 
The black square, red circle, and green triangle are three different devices on a single 
low-density array.  
 
 At a flow rate of 10 mL/min (or 0.167 mL/s) and an effective cell cloning 
cylinder volume of 0.006 mL (approximately one-half of the cloning cylinder due to the 
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space occupied by the inlet and outlet tubes) an amount of solution equal to the volume 
of the chamber cycled through roughly 28 times a second. As would be intuitively 
expected, the time constants have a roughly linear relationship with the SPION 
concentration. With fewer SPIONs flowing through at a constant solution flow rate, 




















































Figure 4.6: Relationship of the extrapolated ID change with SPION concentration 
The black square, red circle, and green triangle are three different devices. 
 
 Interestingly, the extrapolated maximum ID values only vary linearly over three 
orders of magnitude change in SPION concentration. While perhaps initially surprising, 
it is easily explained by considering that the electromagnet ultimately only attracts the 
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SPIONs in solution towards the SiNW and given sufficient time would attract enough 
SPIONs within the Debye screening length to modulate the current similarly, despite 
large changes in concentration. As both the time constant and change in ID versus 
concentration data represent a new type of measurement and follow intuition, they are 
similar to the volume charge density results of Chapter 3 and should be considered initial 
reference points for future tests. 
4.5  Summary 
 This chapter discussed the use of an electromagnet to selectively capture and 
sense functionalized SPIONs in a manner quite similar to that previously used to 
capture, but not sense, circulating cancerous cells. Data derived from the wet 
measurements offered insight into both the capture and sensing processes relevant to 
flow-through systems.  
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5 BIOCHEMICAL SENSING WITH A HIGH-DENSITY ARRAY 
 
5.1 Background 
Despite the clear merits of a scalable sensing platform and the potential of SiNW 
sensors to provide just that, there have previously only been scattershot efforts towards 
truly scaling a completely top-down fabricated SiNW sensor array – incidentally, even 
most of these have been in the area of photoelectronics and charge storage, not 
biosensing. [84-86] 
This chapter discusses two primary topics. The first is the development of a new 
fabrication process that uses elements of 3DS, namely TSVs, to develop an indefinitely 
scalable SiNW high-density sensor array with 10,000 sensors/cm2 – another key step 
towards the realization of the electronic microplate. This is a spiritual extension to a 
different field of the 3DS work performed for stacking memory and logic chips. [87, 88] 
The second is the dry and wet characterization of this sensor array. 
5.2 High-Density Array Fabrication 
The fabrication process was a highly scaled combination of two previously 
discussed methods. The first was the top-down fabricated SiNW array described in 
Chapter 3 and the second was a new TSV fabrication and plating process. [49, 74] The 
process began with the same SOI wafer with the 70 nm device layer (p-type, 1-10 Ω-cm) 
and 144 nm BOX layer as before, but with a thinned 200 μm handle layer to facilitate the 
incorporation of TSVs at high aspect ratios with the processing tools used. The device 
layer face is hereafter referred to as the topside and the handle layer face as the backside.  
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A 2 μm plasma-enhanced chemical vapor deposition (PECVD), (Unaxis) SiO2 
layer, the “mesh” oxide, was deposited on the topside which, in subsequent steps, served 
as the substrate for the mesh and isolating “islands” and also protected the device layer 
during the early processing steps. 40 μm  TSVs, which ultimately functioned as the 
source and drain electrodes, were patterned on the handle layer and then etched using an 
ICP from the backside through the handle, buried oxide, and device layers, stopping at 
the mesh oxide. The sidewalls of the TSVs were passivated from the backside with a 2 
μm PECVD SiO2 layer. 50 μm diameter islands of the mesh oxide centered on the 40 μm 
TSVs were then defined with buffered oxide etchant. This exposed the device layer 
everywhere except around the TSVs. EBL was then used to pattern 25 μm long by 50 
nm wide SiNWs at a pitch of 100 μm (10,000/cm2), which were then anisotropically 
etched with an ICP as in prior discussions. This was followed by a 900°C RTP in O2 
which again had the same function as before. The meshes, a grid pattern of holes in the 
mesh oxide centered on the TSVs, which served as the starting point for electroplating, 
were then etched with a reactive ion etch (RIE), (Vision Oxide).   
A multi-step electroplating processing was then utilized. Au was first deposited on 
top of photoresist, which in turn was on top of the device layer. The Au offered a 
chemically inert electrical contact with the mesh patterns on the TSVs during 
electroplating while the photoresist underneath allowed for a simple lift-off process to 
remove the Au after electroplating without damage to the Cu TSVs, or the Si and SiO2. 
The mesh was first “pinched-off” from the topside in a Cu electroplating solution to 
form an electrical constant from the Au to the TSVs and the TSV was fully plated 
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through from the backside. The Au was finally removed using lift-off – this approach 
eliminated the need to use metal etchants to selectively remove the Au.   
Al electrodes connecting the TSVs with the SiNWs were defined on the topside. A 
400°C RTP (lower than the 450 °C used previously in the low-density array to minimize 
any effects of variances in the coefficient of thermal expansion between the Cu TSVs 
and Si/SiO2) in forming gas formed ohmic contacts between the Al electrodes and 
SiNWs. [89] As a result of this consideration, there were no issues resulting from the 
expansion mismatch between the Cu and Si/SiO2. Finally, the topside was passivated and 
20 μm diameter wells were defined over the TSVs, again with SU-8, but this time in a 
one-step process.  
The fabricated chips therefore had a topside with individually addressable SiNWs 
in isolated wells connected to the backside through TSVs which were used as the drain 
and source contacts. The process workflow is depicted in groups in Figure 5.1, Figure 
5.2, and Figure 5.3 and detailed in Appendix Table 7.4. 
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A     B  
C     D  
 
Figure 5.1: Depiction of the high-density array TSV processing workflow 
A PECVD oxide was first deposited on the backside (A). Next, the TSVs were etched 
from the backside up to the PECVD oxide on the topside (B). The sidewalls were then 
passivated from the backside, again with the PECVD (C). Finally, the PECVD oxide on 
the topside was removed everywhere except for a region centered on the TSVs (D).  The 
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Figure 5.2: Depiction of the high-density array SiNW and metal processing workflow 
EBL and an ICP were used to pattern and define the SiNWs on the topside (A). Next, 
the mesh was etched through the PECVD defined oxide from the topside (B). The TSVs 
were plated, first by using electroplating to pinch off the mesh from the topside and then 
by using electroplating from the backside (C). Electrodes were then deposited to connect 


























Figure 5.3: Depiction of the completed high-density array with wells 
A one-step passivation process defined the wells and protected the electrodes. 
 
 
Figure 5.4: CAD layout of a single high-density chip 











A    B  
C  
Figure 5.5: Images of a fabricated high-density array chip at various stages 
Shown are a 1 x 1 mm of as etched TSVs for a 10 x 10 SiNW array (A), an array of TSVs 
ready for plating (B), and finally, a group of 4 completed SiNWs with wells (C). 
 
5.3 Characterization Measurements 
Again, as for the low-density array, dry and wet measurements were performed. 
The chip was first electrically characterized in dry conditions and then it was 
characterized in PBS based wet conditions. There was a unique requirement for probing 
as the topside with the sensors was no longer the side with the source and drain contacts.  




















To determine the effects of TSV induced performance degradation, two samples 
were fabricated in parallel. The first sample (non-plated) was fabricated with all the steps 
except those required for the TSVs while the second sample (plated) also included all the 
steps required for the TSVs. The source and drain electrodes of the non-plated sample 
were probed from the topside Al electrodes while the source and drain TSVs of plated 
samples were probed from the backside to measure the impact of TSV related processing 
and the TSVs themselves. The final SU-8 passivation step was excluded in both cases so 
that both samples would be as similar in fabrication as possible, while still allowing for 
the non-plated sample to be probed from the topside. This would naturally have not 
been possible with the SU-8 passivating the topside. 
 
A     B  
Figure 5.6: Testing setup for high-density array sensing 
 
 The test configuration was unique compared to prior configurations because of 
the need to be able introduce solutions to the topside sensors, but probe the TSVs from 
the backside. To accomplish this, an insulating cup with a hole in the center held the 
chip topside facing down while allowing the TSVs to be probed. A cell cloning cylinder 







Insulating cup  


















cap with inlet and outlet tubing capped the sample through the hole in the cup. This was 
essentially an upside down version of the flow-through configuration used in Chapter 4. 
Cu tape was used to electrically connect the back-gate with the probestation chuck. This 
configuration was used to measure the plated sample in both dry and wet conditions. 
The non-plated sample still used the cup and Cu tape, but with the topside facing up to 
negate any factors associated with the tape. 
Standard IV and transconductance curves were measured on both sets of 
samples. A representative set of curves are shown in Figure 5.7 and Figure 5.8 for the 
non-plated and plated samples, respectively. VDS = -5 V in the transconductance curves. 
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Figure 5.7: Dry IV and ID and gm vs. VGS curves for a non-plated high-density array 





























































Figure 5.8: Dry IV and ID and gm vs. VGS curves for a plated high-density array   





























 There was not a large performance degradation in terms of both ID and 
transconductance between the plated and non-plated samples The non-plated sample did 
generally exhibit higher drive currents (≈10%) and a higher and broader 
transconductance peak. The drop in ID is, however, larger than would be expected simply 
from the added resistance of the drain and source TSVs – which would be about 106 
mΩ for two 40 μm diameter x 200 μm Cu cylinders assuming bulk Cu resistivity of 
1.68·10-8 Ω·m. The explanation is two-fold. First, the electroplating cannot be expected 
to produce an electrically perfect Cu TSV, but far more likely, much of the performance 
degradation arose from the contact resistance between the Cu TSVs and the Al 
electrodes. It has been previously known that Cu/Al alloys and interfaces may corrode 
and such an interface may have been formed by the last annealing step. [90] A solution 
would be to use a single metal for both the TSVs and electrodes. Unfortunately, the 
plating process with Cu and the Al/Si contact were both well developed in our facility 
and the performance penalty was accepted. 
 Nearest-neighbor TSV leakage measurements were also performed. The array 
design grouped two SiNWs having individual drains with a common source as shown in 
Figure 5.4. This leakage is defined as the current from a drain TSV to the nearest source 
TSV to which it is not connected via a SiNW. These leakage currents were more than 
two of magnitude lower than ID, suggesting adequate TSV sidewall passivation under 
typical biases as shown in Figure 5.9. 
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Figure 5.9: Nearest-neighbor TSV leakage 
Current values below the sensing limits of the parameter analyzer are cutoff.  
 
5.4 pH Ssensing Measurements 
pH sensing measurements in biologically relevant conditions were performed on 
samples fabricated using the complete process, similar to the test configuration of 
Chapter 2, but with PBS at five different pH levels rather than three and in a flow-
through, rather than a well configuration. The topside of the chip was capped with a 2 
mm diameter x 4 mm tall cell cloning cylinder nearly identical to the flow-through setup 
from Chapter 4 as previously mentioned, but into and out of which six tubes (five inlet 
and one outlet) were placed. The entire fixture was sealed with mounting adhesive. The 
 75 
tubing lengths were kept just long enough to extend outside of the probestation 
enclosure to facilitate rapid exchange of solutions. Each of the five inlet tubes was fitted 
with a syringe containing 1x PBS at pH levels of 2.8, 5.0, 7.3, 10.9, and 12.3. pH 7.3 PBS 
was first introduced and a transcondutance measurement was performed at V DS = -5 V 
to establish an optimal biasing point as in prior tests. [29] Next, pH 2.8 PBS was 
introduced and a timed measurement run was performed. After an initial settling period, 
the five PBS solutions with pH values ranging from 2.8 to 12.3 and back down to 2.8 
were sequentially introduced approximately every 100 s. The resulting ID versus time 
curve is shown in Figure 5.10. 
















Figure 5.10: Time-dependent response to varying pH solutions 
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The flow-through configuration again allowed for far lower hysteresis during 
solution exchanges than the well configuration of Chapter 2.  The sensitivity (defined as 
the change in ID for a unit change in pH) was ≈50 nA/pH above a pH of 5. The non-
linear response of the sensors below a pH of 5 is typical of unfunctionalized SiO2 
surfaces terminating only in hydroxyl groups. [26] The ID versus pH curve is shown in 
Figure 5.11. 
















Figure 5.11: ID versus pH for a high-density array 
The square, circle, and triangle are three different devices and the line is the average of 
the three. 
 
 The linear change in ID with logarithmic changes in H
+ and OH- concentration is 
identical to the discussion about log-linear relationships in Chapter 3 and has in fact 
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been experimentally observed by all SiNW sensors operated in the linear region. [26, 37, 
38] 
While the high-density array was operated in a flow-through configuration here, it 
could also be used in a spotting configuration, as in Chapter 3, with the appropriate nano 
or micro-scale biochemical spotting tool. [91, 92] This was not a readily accessible 
resource during the course of this work, but there is no inherent limitation toward using 
the tool. In fact, this would be the most logical configuration of an electronic microplate 
with numerous individually addressable sensors as it would bypass the aforementioned 
complexities of microfluidics.  
5.5 Refinements 
There remains room to maximize yield, which was roughly 10 % compared to the 
better than 90 % yield with the low-density array. The drop relative to the test and low-
density arrays was the result of the substantial increase in fabrication complexity.  The 
two most common causes of sensor failure were either a poorly defined mesh that led to 
failed electroplating of that TSV or, more commonly, a short from the source or drain to 
the gate. The cause of the source or drain to gate shorts was the electroplated copper 
coming into contact with the carrier layer Si near the topside during pinch-off due to 
poor alignment of the island or mesh, leading to removal of the relatively thin BOX layer 
during either the BOE etching of the islands or RIE etching of the mesh, respectively or 
damage to the passivating sidewall oxide. A schematic comparison of the plated and non-
plated samples is available in Figure 7.1 of the Appendix. 
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These are not fundamental limitations of the process conceptually, but rather the 
result of the alignment limits of the available optical lithography tools over the multiple 
lithography steps under fairly tight tolerances for the high-density array (≈5 μm for all 
patterning steps in sum). This was made more challenging over previous work because of 
the addition of the islands, the use of SOI wafers, and the need to have working sensors 
at the end. A lithography setup with better alignment and resolution capabilities along 
with, and equally importantly, better controlled etch process flows would mitigate or 
eliminate these issues, even in a multi-user facility.  
Recent industry developments in non-planar CMOS and 3DS technologies 
suggest that such a configuration would be entirely reasonable to manufacture in a large-
scale and commercially viable process with perhaps even a near complete mitigation of 
the any performance tradeoffs. [93, 94] 
5.6 Summary 
 This chapter discussed the fabrication and characterization of a high-density 
SiNW sensor array using a CMOS compatible process incorporating TSVs. Fundamental 
electrical measurements demonstrated that the sensor array could function as a pH 
sensor in PBS.  
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6 CONCLUSIONS AND FUTURE WORK 
 
6.1 Summary 
 The work described in this dissertation really started with the broad goal of 
visualizing what a next-generation biosensing platform might look like. The end result, 
the idea of the electronic microplate, is a combination of the tremendous advances in 
biology and microelectronics over the last half-century. 
 
The key contributions of this work were: 
 
-  Envisioning an idea for a highly scalable general purpose next-generation 
 biosensing platform  
-  Establishing a fully top-down CMOS compatible workflow for label-free sensor 
 array fabrication using methods used in emerging non-planar devices 
-  Demonstrating the first label-free delineation of healthy and cancerous ovarian 
 epithelial cell lines using intracellular contents 
-  Demonstrating the first label-free capture and detection of functionalized 
 SPIONs 
-  Establishing the workflow for and demonstrating the first truly high-density 
 label-free sensor array 
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6.2 Future Work 
 Perhaps the most exciting aspect of starting on a new idea are the possibilities 
that lie in extending that idea. While the work described in this dissertation implemented 
fundamental elements of the electronic microplate, there are numerous contributions 
that remain to be made, as would be expected of most courses of work. These 
extensions can be categorized into two parallel groups. The first is in applications and 
the second is in scaling the sensing and electronics layers. 
 In terms of applications, there are many current bioassays which might be 
directly transferable to a label-free technology. Examples range from gene sequencing to 
current clinical assays such as lipid profile tests. Even entire processes such as 
polymerase chain reactions could be carried out on the electronic microplate. There is 
really no fundamental limit to what bioassays could be transferred to this electronic 
sensing platform. 
 In terms of scaling the components of the platform, fleshing out the constituent 
layers will certainly be worthwhile. First would be the development of reliable and high-
density compliant interconnects suited for this role. Second would be the development 
of a general purpose electronics layer that can control a variety of electronic microplates 
possessing a broad range of sensing capabilities. 
 One general suggestion would be to outsource key technologies after 
demonstration on the fabrication side while keeping biological development in-house. 
There is a very large delta in the capabilities of multi-user cleanrooms and foundries. It 
would be ideal to initially use the flexibility afforded by multi-user cleanrooms before 
transferring the designs to the robust fabrication afforded by foundries.  
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 Physically, the sensing layer and the electronics layer are rather simple elements 
that are enablers for a multitude of sensing applications. It might perhaps even be wise 
to make transferring the fabrication of the sensing layer to a foundry the first priority 
and the electronics layer the second priority. With a reliable source of the physical 
components, there would be opportunities to fully explore the real capabilities of this 
platform – which really lie in exciting new biochemical sensing applications. There is no 
doubt tremendous potential in applications such as ubiquitous clinical screenings, 





7.1 Device Si, BOX, and HSQ Etch Rates 
Table 7.1: Device Si, BOX, and HSQ etch rates 
Spin-Chip 
Average Etched Materials by SOE (nm) Etch Rate (nm/s) 
Si BOX HSQ Si BOX HSQ 
1-1 70.5 1.6 21.1 5.9 0.8 1.5 
1-2 70.5 5.3 27.8 5.9 1.1 1.6 
1-3 70.5 7.9 34.9 5.9 1.0 1.7 
Control 0.0 0.0 0.0 0.0 0.0 0.0 
2-5 70.5 1.6 17.6 5.9 0.8 1.3 
2-6 70.5 6.6 30.1 5.9 1.3 1.8 
2-7 70.5 8.0 30.0 5.9 1.0 1.5 
Control 0.0 0.0 0.0 0.0 0.0 0.0 
 
Spin-Chip 
Average Etched Materials by BOE (nm) Etch Rate (nm/s) 
Si BOX HSQ Si BOX HSQ 
1-1 0.0 7.9 21.4 0.0 2.0 5.3 
1-2 0.0 4.7 14.2 0.0 2.4 7.1 
1-3 0.0 4.0 9.5 0.0 2.0 4.7 
Control 0.0 0.0 0.0 0.0 0.0 0.0 
2-5 0.0 7.3 18.3 0.0 1.8 4.6 
2-6 0.0 5.4 9.4 0.0 2.7 4.7 
2-7 0.0 5.1 4.6 0.0 2.5 2.3 
Control 0.0 0.0 0.0 0.0 0.0 0.0 
 
Spin 
Average Etch Rates (nm/s), RAMA_SI Standard Deviation (nm/s) 
Si BOX HSQ Si BOX HSQ 
1 5.9 0.9 1.6 0.0 0.1 0.1 
2 5.9 1.0 1.5 0.0 0.3 0.3 
Cumulative 5.9 1.0 1.6 0.0 0.2 0.2 
 
 Table 7.1 details the characterization of Si, BOX, and HSQ etch rates during dry 
etching in the ICP and wet etching in BOE.  
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7.2 Process Development Fabrication Workflow 
Table 7.2: Process development fabrication workflow 
Step Chemical/Tool Process 
SiNW 6% HSQ 5000rpm, 2500rpm/s, 40s 
    250C, 60s 
    RD6, 60s, 10% RD6, 60s 
  EBL SNR082208 
  STS SOE RAMA_SI, 18s 
RTP Oxide AET RTP RAMA_O, O2, 900C, 2min, ramp up in 1min 
Metallization   5s BOE 
  NR9-1500PY 150C hotplate, 60s 
    589mJ, 365nm 
    
100C hotplate, 60s 
RD6, 12s 
  E-beam Al, 100nm, 2A/s 
RTP Annealing AET RTP RAMA_M, FG, 400C, 5min, ramp up in 1 min 
Passivation SU-8 2002 2000rpm, 300rpm/s, 30s 
    95C hotplate, 90s 
    90mJ, 365nm 
  95C hotplate, 60s 
  SU-8 developer, 60s 
 
  
 Table 7.2 details the workflow used to fabricate the devices described in Chapter 
2. All the tools were part of the Georgia Institute of Technology Nanotechnology 
Research Center.  
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7.3 Low-Density Array Fabrication Workflow 
Table 7.3: Low-density array fabrication workflow 
Step Chemical/Tool Process 
SiNW 2% HSQ 4000rpm, 2000rpm/s, 40s 
    180C, 3min 
    RD6, 60s, 10% RD6, 60s 
  EBL SNR031009 
  STS SOE RAMA_SI, 18s 
RTP Oxide AET RTP RAMA_O, O2, 900C, 2min, ramp up in 1min 
Metallization   5s BOE 
  NR9-1500PY 150C hotplate, 60s 
    589mJ, 365nm 
    
100C hotplate, 60s 
RD6, 12s 
  E-beam Al, 100nm, 2A/s 
RTP Annealing AET RTP RAMA_M, FG, 450C, 5min, ramp up in 1 min 
Passivation SU-8 2002 2000rpm, 300rpm/s, 30s 
    95C hotplate, 90s 
    90mJ, 365nm 
    95C hotplate, 60s 
    SU-8 developer, 60s 
Wells SU-8 2050 1700rpm, 300rpm/s, 30s 
    65C oven, 5min, 95C oven, 15min 
    230mJ, 365nm 
    65C oven, 3min, 95C oven, 9min 
    SU-8 developer, 8min 
 
 Table 7.3 details the workflow used to fabricate the devices described in Chapters 
3 and 4. All the tools were part of the Georgia Institute of Technology Nanotechnology 
Research Center.  
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7.4 High-Density Array Fabrication Workflow 
Table 7.4: High-density array fabrication workflow 
Step Chemical/Tool Process 
Mesh Oxide Unaxis PEVCD RAMA_OX, 33min 
TSV NR5-8000 600rpm, 100rpm/s, 50s 
    100C oven, 15min 
    554mJ, 365nm 
    75C oven, 8min 
    RD6, 50s 
  STS ICP RAMA_TSV, ~700 cycles 
SiO2 Island SC1827 2500rpm, 500rpm/s, 30s 
    100C hotplate, 3min 
    185mJ, 365nm 
    RD6, 40s 
  BOE ~6min 
Sidewall Passivation Unaxis PECVD RAMA_OX, 33min 
SiNW 2% HSQ 4000rpm, 2000rpm/s, 40s 
    180C, 3min 
  EBL SNR012210 
    RD6, 60s, 10% RD6, 60s 
  STS SOE RAMA_SI, 18s 
RTP Oxide AET RTP RAMA_O, O2, 900C, 2min, ramp up in 1min 
Mesh NR9-1500PY 800rpm, 500rpm/s, 40s 
    150C hotplate, 60s 
    589mJ, 365nm 
    100C hotplate, 60s 
    RD6, 24s 
  Vision Oxide 1 STDOX_200, ~60min 
Seed Layer NR9-1500PY 5000rpm, 1000rpm/s, 40s 
    150C hotplate, 60s 
    589mJ, 365nm 
    100C hotplate, 60s 
    RD6, 12s 
  E-beam Cr/Au, 10/1000nm, 2A/s 





NR9-1500PY 5000rpm, 1000rpm/s, 40s 
  
150C hotplate, 60s 
    589mJ, 365nm 
    
100C hotplate, 60s 
RD6, 12s 
  E-beam Al, 100nm, 2A/s 
RTP Annealing AET RTP RAMA_M, FG, 400C, 5min, ramp up in 1 min 
Passivation SU-8 2002 2000rpm, 300rpm/s, 30s 
    95C hotplate, 90s 
    90mJ, 365nm 
    95C hotplate, 60s 
 
  SU-8 developer, 60s 
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 Table 7.4 details the workflow used to fabricate the devices described in Chapter 
5. All the tools were part of the Georgia Institute of Technology Nanotechnology 
Research Center. 
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